Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data

Recent results from the phase 3 trial of RTS,S/AS01 malaria vaccine show that the vaccine induced partial protection against clinical malaria in infants and children; given the high burden of the disease it is currently considered for use in malaria endemic countries. To inform adoption decisions th...

Descripción completa

Detalles Bibliográficos
Autores principales: Galactionova, Katya, Bertram, Melanie, Lauer, Jeremy, Tediosi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357730/
https://www.ncbi.nlm.nih.gov/pubmed/26518406
http://dx.doi.org/10.1016/j.vaccine.2015.10.079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357730/
https://www.ncbi.nlm.nih.gov/pubmed/26518406
http://dx.doi.org/10.1016/j.vaccine.2015.10.079

Ejemplares similares